- Advertisement -
- Advertisement -
- Advertisement -

Find a job

Subscribe for free

All things Pharma


Key covid-19 updates, government guidance and insight for pharma and health.


NICE guidance does not recommend AstraZeneca’s Evusheld

The National Institute for Health and Care Excellence (NICE) has issued draft guidance for public consultation which does not recommend Evusheld (tixagevimab-cilgavimab) for preventing...
- Advertisement -

Sanofi and GSK submit data for their COVID-19 vaccine

Sanofi and GlaxoSmithKline (GSK) have announced that they intend to submit data from both...

Success for world’s largest study into new antiviral treatments against COVID-19

Over ten thousand participants from across the UK have now taken part in the...

JCVI updates COVID-19 vaccination guidance for 5 to 11 year olds

The Joint Committee on Vaccination and Immunisation (JCVI) is now advising a non-urgent offer...
- Advertisement -
- Advertisement -

Pfizer and BioNTech initiate clinical study of Omicron vaccine

Pfizer and BioNTech have announced the initiation of a clinical study to evaluate the safety,...

MHRA approves Pfizer’s COVID-19 antiviral treatment Paxlovid

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved COVID-19 antiviral treatment, Paxlovid...

UK marks 132 million COVID-19 vaccinations in 2021

Around 132 million COVID-19 vaccinations were administered across all four nations of the UK in 2021, as part of the largest vaccination programme in...

COVID: A new wave of interest in pharma, what learnings can we take into the future?

"We have a responsibility to build on this extraordinary period of self-education and find ways of talking about what we do – beyond vaccines"


Sign up to receive our digital newsletter, for all the essential headlines, Jobs of the Week and thought-provoking features.

Claim my free subscription